KBC Group NV »

Mbx Biosciences shares owned by KBC Group NV

Quarter-by-quarter ownership of Mbx Biosciences (MBX) shares owned by KBC Group NV from 13F filings

Historical chart of KBC Group NV investment in Mbx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Mbx Biosciences held by KBC Group NV consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mbx Biosciences by KBC Group NV

Quarter filed Position value Share count Share price at filing
2026-03-31 $24k 810 29.63

More positions owned by KBC Group NV

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Bank of America Corporation (BAC)
Citigroup Com New (C)
Gilead Sciences (GILD)
Lam Research Corp Com New (LRCX)
Johnson & Johnson (JNJ)

View all positions for KBC Group NV

Top funds holding Mbx Biosciences

Frazier Life Sciences Management
OrbiMed Advisors
NEA Management Company
Wellington Management Company
BlackRock
Deep Track Capital
NVP Associates
Vanguard Group
Braidwell
Vanguard Capital Management
Driehaus Capital Management
Aaron Wealth Advisors
Cormorant Asset Management
Citadel Advisors
Kynam Capital Management

View all funds holding Mbx Biosciences